Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer

Women with history of tumor response insufficient to allow complete cytoreductive surgery after three cycles of previous neoadjuvant systemic carboplatin-paclitaxel chemotherapy will be prospectively recruited in this trial. After signed consent and if unresectability is confirmed, patients will undergo three cycles of doxorubicin-cisplatin PIPAC chemotherapy associated with systemic carboplatin-paclitaxel chemotherapy (alternating PIPAC and intravenous chemotherapy sessions over 3 cycles of 4 weeks). Since the 7th amendment of the study, sodium thiosulfate as nephrtoxicity prevention has bee

Trial Details

NCT ID
NCT04811703
Phase
PHASE1
Sponsor
Hospices Civils de Lyon
Status
RECRUITING
Cancer Type
Ovarian Cancer
Interventions
  • Combined PIPAC / IV chemotherapy treatment
Locations (sample)
  • Lille, France|50.63391,3.05512
  • Lille, France|50.63391,3.05512
  • Lyon, France|45.74906,4.84789
  • Pierre-Bénite, France|45.70359,4.82424
  • Pierre-Bénite, France|45.70359,4.82424

Key Eligibility Criteria

  • Age ≥ 18 years and ≤ 75 years;
  • ECOG Performance Status 0-2;
  • Histologically confirmed epithelial carcinoma of the ovary, fallopian tubes, or peritoneum, FIGO stage IIb to IVa, with a tumor response after thre…
  • Adequate hematological function:

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Ovarian Cancer Trials on Trialify →